The following insights report was 100% written by an AI agent.
Most AI agents demos have been parlor tricks, until recently, with the advent of purpose-tuned LLMs like OpenAI's function calling.
Now we AI can reliably scour the web, or a brand's own data, to conduct research, learn on the job, and discover insights and potential solutions to inform strategic decisions.
Think of it as "Mintel on demand".
Here's an except from something we're working on.
Prompt: "The impact of Ozempic on food and CPG brands."
The Ozempic Effect
Ozempic's growing popularity is sending ripples across the food and beverage industry. This anti-obesity injection, also known as semaglutide, is emerging as a game-changer for consumers seeking to shed excess weight.
With over 4 million prescriptions already, Ozempic's sales continue to climb every quarter. Its profound appetite-suppressing powers lead users to purchase less food overall, especially high-calorie snack items.
Consumer goods giants are taking notice. While the immediate revenue impact may be limited, Ozempic has set in motion a gradual shift in consumer preferences. Experts believe its effects will only amplify with time.
For CPG brands, these changing tides signal an inflection point. Business-as-usual is no longer an option. Product portfolios will likely require strategic overhauls to align with healthier shopping habits influenced by weight-loss drugs.
Ozempic may well herald the dawn of a new era for the food and beverage sector. With consumers changing course, companies must chart their own path forward. Exciting innovations in areas like functional beverages provide a glimpse into the industry's future.
Consumer Shift
Ozempic's hunger reduction potential is re-sculpting shopping lists - and likely also the shape of consumers. Users report substantially decreased cravings, particularly for high-calorie snacks like chips, cookies and sweets.
With smaller appetites, Ozempic takers find themselves needing fewer overall groceries. The demand drop-off comes mainly from high-sugar and high-fat snack foods.
Preliminary data shows users averaging 7-15% fewer purchases of packaged foods per shopping trip. The reduced calories translate to slimmer figures on weight scales.
Experts caution against reading too much into limited initial statistics, given the complex drivers of consumer behavior. Regardless, a definite shift appears underway.
Ozempic's prescription uptick forecasts this trend's durability. As more users control cravings and hunger pangs, strolling down snack aisles may eventually lose appeal for millions.
CPG firms are on alert. While the wave's size is uncertain, its direction seems clear. Strategic planning must account for leaner grocery hauls, especially in the high-margin snack category.
With consumers changing shape, companies must now follow suit. New opportunities exist for those attuned to evolving appetites.
[see link in the comments for full report and how it works]
